Celebrating 25 Years of Lipitor: Leading the Way in Dyslipidemia Treatment Strategies
Lipitor’s 25th Anniversary… Ranked #1 in Statin Combination Prescriptions for Single and Combination Drugs Effect of prevention of cardiovascular diseases, abundance of clinical data, “trust” in medical personnel The key to treating dyslipidemia is “cardiovascular effects”… Contribute to the development of treatment strategies “Lipitor has increased clinical awareness of the importance of treating dyslipidemia over […]
K-MELLODY Project Group: Accelerating New Drug Development with Collective Learning-Based Approach
Pharmaceutical and Biotechnology Association opens K-MELLODY business unit Resolve data distribution issues and maximize research efficiency Choose detailed business in June, start first year project in July On the 17th, the Korea Pharmaceutical and Biotechnology Society held an opening ceremony for the ‘Collective Learning-Based New Drug Development Acceleration Project Team’ (K-MELLODY Project Group) at the […]
Breakthrough Chlamydia Vaccine Shows Promise in Clinical Trials: 100% of Participants Develop Antibodies
100% of people who receive the chlamydia vaccine develop neutralizing antibodies Posted on 04.13.2024 at 9.00pm Posted on 04.13.2024 at 9.00pm Modified on 04.13.2024 at 5.48pm Views 0 Chlamydia is a sexually transmitted bacterial disease transmitted by the bacterium Chlamydia trachomatis and is considered one of the most common causes of female infertility. [사진=게티이미지뱅크]CTH522, developed […]
‘History of Korean clinical trials’ Korea Clinical Development Research Association “We will become a spokesperson for the clinical-related industry”
Yoonhee Lim, 8th President of the Korea Clinical Development Research Association 1999. This is the year that Korea began global clinical trials in earnest. At the center of clinical trials in Korea, which has grown rapidly in about 25 years, is the Korea Clinical Development Research Association. The Korea Clinical Development Research Association has changed […]
Hope for Patients: GLP-1 Analogs and Degenerative Brain Diseases
Money Today reporter Lee Chang-seop | 01.30.2024 05:10 Attention is being paid to whether weight loss and obesity could be a source of hope for patients with dementia and Parkinson’s disease. Two clinical trials for the treatment of patients with Alzheimer’s disease and Parkinson’s disease using GLP-1 (glucagon-like peptide-1) analogues will be completed in the […]
Clinomics Successfully Completes Clinical Evaluation for Early Diagnosis of Lung Cancer Using Blood-Based Technology
[이데일리 나은경 기자] Clinomics (352770) announced on the 25th that it has successfully completed a clinical evaluation of the technology to accurately distinguish and diagnose cancer patients and benign lung diseases (pneumonia, tuberculosis, noncancerous granulomas, etc.) in early stages. This study was conducted jointly with Professor Injae Oh’s team at Hwasun Hospital of Chonnam National […]
Clinomics Successfully Completes Clinical Evaluation for Early Lung Cancer Detection Technology
[이데일리 나은경 기자] Clinomics (352770) announced on the 25th that it has successfully completed a clinical evaluation of the technology to accurately distinguish and diagnose cancer patients and benign lung diseases (pneumonia, tuberculosis, noncancerous granulomas, etc.) in early stages. This study was conducted jointly with Professor Injae Oh’s team at Hwasun Hospital of Chonnam National […]
Domestically Developed Third-Generation Monkeypox Vaccine Enters Phase 1 Clinical Trials
Money Today reporter Lee Chang-seop | 25.01.2024 16:35 The domestically developed third-generation monkeypox vaccine is expected to enter phase 1 in the second half of the year Research conducted for 24 months… Phase 2 clinical trial and commercialization preparation The world’s only third-generation vaccine must be developed domestically to ensure vaccine sovereignty A domestically developed […]
Vigencell’s Life-Saving New Drug Candidate Showcases Promising Results
Money Today reporter Kim Do-yoon | 25.01.2024 16:36 Vigencell is currently conducting Phase 2 clinical trials of its lead immuno-oncology drug and is accelerating to commercialization next year. Expectations are high as this is a new drug candidate that has achieved a 100% overall survival rate in real-world patient studies. In addition, the development of […]
Development of Clinical-Grade Dopamine Cells from Embryonic Stem Cells for Parkinson’s Disease Therapy
Revolutionary Research on Parkinson’s Disease Treatment Paving the way for a breakthrough in Parkinson’s disease treatment, a joint research team led by Professor Kim Dong-wook of Yonsei University College of Medicine has successfully developed high-yield, clinical-grade dopamine cells derived from embryonic stem cells. This groundbreaking achievement has opened new doors for the development of advanced […]
